Mason Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-19,676
Closed -$1.28M 85
2019
Q4
$1.28M Sell
19,676
-43
-0.2% -$2.8K 0.19% 39
2019
Q3
$1.25M Buy
19,719
+2,790
+16% +$182K 0.2% 35
2019
Q2
$1.14M Buy
16,929
+1,454
+9% +$95.7K 0.19% 37
2019
Q1
$1.01M Buy
+15,475
New +$1.03M 0.28% 40

Other funds holding GILD

Mason Investment Advisory Services's GILD Position: Q1 2020 in Review

Mason Investment Advisory Services sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 19,676 shares — an estimated $1.28M sold.

Mason Investment Advisory Services first reported a position in GILD in Q1 2019 and held it in 4 quarters. The position peaked at $1.28M in Q4 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Mason Investment Advisory Services reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Mason Investment Advisory Services sold 19,676 Gilead Sciences shares in Q1 2020, an estimated $1.28M.
  • Mason Investment Advisory Services first reported a position in Gilead Sciences in Q1 2019 and held it in 4 quarters.
  • Mason Investment Advisory Services's Gilead Sciences position peaked at $1.28M in Q4 2019.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Mason Investment Advisory Services's 13F filing for Q1 2020, filed 5 Aug 2024.